Patents by Inventor Joon-Yee JEONG

Joon-Yee JEONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCERS ASSOCIATED WITH KRAS MUTATION
    Publication number: 20230346790
    Abstract: A pharmaceutical composition for preventing or treating cancer, which is associated with a KRAS mutation and exhibits resistance to an EGFR-targeted therapeutic agent is disclosed. The pharmaceutical composition can be useful for treatment of patients with cancer which has the KRAS mutation and exhibits resistance to cetuximab that is an anticancer therapeutic agent. A method for providing information on an anticancer treatment and/or enhancing cancer treatment by identifying a KRAS mutation and optionally additionally a RON mutation are disclosed.
    Type: Application
    Filed: February 5, 2021
    Publication date: November 2, 2023
    Applicant: WELLMARKER BIO CO., LTD.
    Inventors: Jae-Sik SHIN, Jung-Eun LEE, Joon-Yee JEONG, Min-Ki LEE, Hyo-Jin KIM, Soon-Jin CHOI, Ji-Hyun GO
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PANCREATIC CANCER ASSOCIATED WITH RON MUTATION AND METHOD USING SAME
    Publication number: 20230242521
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating pancreatic cancer associated with a RON mutation and a method using the same. The pharmaceutical composition for preventing or treating cancer according to the present invention may be applied to patients with pancreatic cancer in which a RON mutation is present. In particular, the present invention may be usefully used as a precision medicine for patients with pancreatic cancer which has resistance to cetuximab used in conventional anticancer therapy and has the RON?155, RON?160, or RON?165 mutation.
    Type: Application
    Filed: May 18, 2021
    Publication date: August 3, 2023
    Inventors: Hyun RYU, Joon-Yee JEONG, Young-Ok KO, Da-Eun KIM, Min-Hwa KIM, Eun-Hee KO
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NON-SMALL CELL LUNG CANCER ASSOCIATED WITH RON MUTANTATION, AND METHOD USING SAME
    Publication number: 20230241073
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating non-small cell lung cancer associated with a RON mutation, and to a method using the same. A pharmaceutical composition for preventing or treating cancer according to the present invention may be applied to patients with non-small cell lung cancer in which a RON mutation is present. In particular, the pharmaceutical composition may be usefully used as a precision medicine in the treatment of patients with non-small cell lung cancer which has resistance to cetuximab used in conventional cancer therapy and has the RON?155, RON?160, or RON?165 mutation.
    Type: Application
    Filed: May 18, 2021
    Publication date: August 3, 2023
    Inventors: Joon-Yee JEONG, Min-Ki LEE, Yong-Seok KIM, Tae-Young KIM, Ji-Hyun KO, Min-Hwa KIM, Eun-Hee KO, Seung-Geon BAE
  • BIOMARKER-BASED THERAPEUTIC COMPOSITION
    Publication number: 20230172914
    Abstract: A method for treating cancer in a patient who is resistant to a protein kinase inhibitor, administering an anticancer agent containing, as an active ingredient, a thienopyridine derivative compound or a pharmaceutically acceptable salt thereof is disclosed. Here, the patient may carry active RON. In addition, the patient may carry normal KRAS gene. In addition, the anticancer agent may be applied to a patient who is resistant to an EGFR inhibitor. In particular, the anticancer agent may be usefully used to treat a patient who is resistant to the therapeutic agent cetuximab.
    Type: Application
    Filed: September 6, 2019
    Publication date: June 8, 2023
    Applicant: WELLMARKER BIO CO., LTD.
    Inventors: Seung-Woo HONG, Jai-Hee MOON, Jae-Sik SHIN, Joseph KIM, Yoon-Sun PARK, Min-Ki LEE, Joon-Yee JEONG, So-Hee LEE, Soon-Jin CHOI